Skip to main content

GSK · GSK plc · Debt

Track GSK — free
$48.58 -0.66 (-1.34%) At close · Nov 18 Q3 2026 earnings call transcript
Market Cap
$97.38B
Shares
2.00B
Volume · Nov 18 2.2M Avg daily vol (3M) 4.03M

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Read debt and covenant terms in your AI or your code through MCP and the API →

Reported debt balances

Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.

Reported balanceAs ofAmountSource
Borrowings 2025-12-31 GBP 14,453,000,000 20-F filed 2026-03-06
Related accounting measures — not additional borrowing

Carrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year.

Noncurrent long-term borrowings
GBP 14,708,000,000
Short-term borrowings
GBP 3,012,000,000
Debt instruments issued 2025-12-31 GBP 16,890,000,000 20-F filed 2026-03-06
Lease liabilities 2025-12-31 GBP 830,000,000 20-F filed 2026-03-06
Related accounting measures — not additional borrowing

Carrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year.

Current lease liabilities
GBP 137,000,000
Noncurrent lease liabilities
GBP 693,000,000
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.

Key facts CIK 1131399 CUSIP 37733W204 13F (30d) 922 filings 845 filers Visit website Investor relations